Polar Light Ventures
Providing investment to early-stage companies backed by strong entrepreneurs
Polar Light Ventures
Polar Light Ventures focuses on Seed Stage
Technology Investments in Europe and the US, with outstanding entrepreneurs and highly scalable business models.
Polar Light Ventures focuses on Seed Stage
Technology Investments in Europe and the US, with outstanding entrepreneurs and highly scalable business models.
We actively support our founders
and portfolio companies to
achieve their goals by
leveraging our extensive
global network
What’s new in our portfolio
AI shown to outperform human experts for skin cancer detection
LONDON, Aug. 29, 2024 (HEALTH TECH WORLD) — A new report commissioned by NHS England (NHSE): Evaluating Pathways for AI Dermatology in Skin Cancer Detection states Skin Analytics’ Artificial Intelligence as a Medical Device (AIaMD), DERM, can be used autonomously in the NHS…
Mobile and at-home veterinary care providers announce merger
NEW YORK CITY, Oct. 22, 2024 (DVM 360) — The Vets, a provider of at-home veterinary care, recently announced it will be fusing with BetterVet, a mobile veterinary service that focuses on at-home visits and telehealth…
Fresha invests in AI-powered hair colour technology company Yuv
LONDON, October 22, 2024 (theindustry.beauty) – Fresha, the marketplace for beauty services, has announced a new strategic investment and partnership with AI-powered hair colour technology company, Yuv…
Biosplice Therapeutics Announces Initiation of Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) Trial Sponsored by the National Cancer Institute (NCI)
SAN DIEGO, Sept. 12, 2024 (GLOBE NEWSWIRE) — Biosplice expands its clinical candidate, cirtuvivint, as standalone treatment and combination therapy in patients with AML and MDS, representing next step in ongoing collaboration with the NCI…